Shanghai No.1 Pharmacy Co Ltd operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai No.1 Pharmacy Co Ltd with three other
drug stores in Asia:
Sapporo Clinical Laboratory Inc.
sales of 17.06 billion Japanese Yen [US$151.45 million]
of which 62%
was Dispensing Pharmacy Business),
Medical Ikkou Co Ltd
(29.49 billion Japanese Yen [US$261.87 million]
of which 75%
was Pharmacies), and
Apex Healthcare Bhd
based in Malaysia
(620.26 million Malaysian Ringgits [US$149.43 million]
of which 94%
was Wholesale and Distribution).
During the year ended December of 2017, sales at
Shanghai No.1 Pharmacy Co Ltd were 1.56 billion Chinese Renmimbi (US$224.61 million).
increase of 2.5%
versus 2016, when the company's sales were 1.52 billion Chinese Renmimbi.
This was the fourth straight year of sales growth at Shanghai No.1 Pharmacy Co Ltd.
Sales of Other Operation saw an increase
that was more than double the company's growth rate: sales were up
5.1% in 2017, from
56.85 million Chinese Renmimbi to 59.75 million Chinese Renmimbi.
Shanghai No.1 Pharmacy Co Ltd also saw significant increases in sales in
Wholesale Trade (up 4.2% to 832.55 million Chinese Renmimbi)